Platania CBM - Search Results

1

Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.

Santonocito M, Zappulla C, Viola S, La Rosa LR, Solfato E, Abbate I, Tarallo V, Apicella I, Platania CBM, Maugeri G, D'Agata V, Bucolo C, De Falco S, Mazzone MG, Giuliano F. Santonocito M, et al. Among authors: platania cbm. Int J Mol Sci. 2021 Apr 22;22(9):4404. doi: 10.3390/ijms22094404. Int J Mol Sci. 2021. PMID: 33922399 Free PMC article.

2

Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.

Platania CB, Salomone S, Leggio GM, Drago F, Bucolo C. Platania CB, et al. PLoS One. 2012;7(9):e44316. doi: 10.1371/journal.pone.0044316. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970199 Free PMC article.

3

Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy.

Bucolo C, Marrazzo G, Platania CB, Drago F, Leggio GM, Salomone S. Bucolo C, et al. J Diabetes Res. 2013;2013:432695. doi: 10.1155/2013/432695. Epub 2013 May 23. J Diabetes Res. 2013. PMID: 23762874 Free PMC article.

4

Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline.

Platania CB, Leggio GM, Drago F, Salomone S, Bucolo C. Platania CB, et al. Biochem Pharmacol. 2013 Nov 1;86(9):1347-56. doi: 10.1016/j.bcp.2013.08.010. Epub 2013 Aug 17. Biochem Pharmacol. 2013. PMID: 23962442

5

Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.

Bucolo C, Marrazzo G, Platania CB, Romano GL, Drago F, Salomone S. Bucolo C, et al. J Pharm Pharmacol. 2014 Jul;66(7):954-60. doi: 10.1111/jphp.12224. Epub 2014 Feb 12. J Pharm Pharmacol. 2014. PMID: 24697218

6

Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles.

Leonardi A, Bucolo C, Romano GL, Platania CB, Drago F, Puglisi G, Pignatello R. Leonardi A, et al. Int J Pharm. 2014 Aug 15;470(1-2):133-40. doi: 10.1016/j.ijpharm.2014.04.061. Epub 2014 May 2. Int J Pharm. 2014. PMID: 24792979

7

Controversies in Glaucoma: Current Medical Treatment and Drug Development.

Bucolo C, Platania CB, Reibaldi M, Bonfiglio V, Longo A, Salomone S, Drago F. Bucolo C, et al. Curr Pharm Des. 2015;21(32):4673-81. doi: 10.2174/1381612821666150909095553. Curr Pharm Des. 2015. PMID: 26350532 Review.

8

MicroRNA target prediction in glaucoma.

Romano GL, Platania CB, Forte S, Salomone S, Drago F, Bucolo C. Romano GL, et al. Prog Brain Res. 2015;220:217-40. doi: 10.1016/bs.pbr.2015.04.013. Epub 2015 Jun 30. Prog Brain Res. 2015. PMID: 26497793 Review.

9

TGF-β1 prevents rat retinal insult induced by amyloid-β (1-42) oligomers.

Fisichella V, Giurdanella G, Platania CB, Romano GL, Leggio GM, Salomone S, Drago F, Caraci F, Bucolo C. Fisichella V, et al. Eur J Pharmacol. 2016 Sep 15;787:72-7. doi: 10.1016/j.ejphar.2016.02.002. Epub 2016 Feb 2. Eur J Pharmacol. 2016. PMID: 26845696

10

Current drug treatments targeting dopamine D3 receptor.

Leggio GM, Bucolo C, Platania CB, Salomone S, Drago F. Leggio GM, et al. Pharmacol Ther. 2016 Sep;165:164-77. doi: 10.1016/j.pharmthera.2016.06.007. Epub 2016 Jun 22. Pharmacol Ther. 2016. PMID: 27343365 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters